An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell therapy in patients with severe, treatment-refractory autoimmune diseases.
Oct 6, 2026
0
5
Nearly 1 in 3 patients with systemic lupus erythematosus (SLE) are taking a supplement-medication combination with potential for an interaction, according to a study published online Sept. 22 in Arthritis Care & Research.
Oct 6, 2026
0
4
For patients with inflammatory arthritis, holding certain disease-modifying antirheumatic drugs (DMARDs), namely select biologic or Janus kinase inhibitor (JAKi) therapies, for two weeks at the time of a supplemental COVID-19 ...
Oct 6, 2026
0
9
A multicenter study led by researchers at Sultan Qaboos University has found that patients with a rare inherited form of lupus may continue to accumulate organ damage even when conventional measures indicate that their disease ...
Oct 6, 2026
0
6
Researchers from University of Michigan Health have mapped the cellular path of inflammation after UV exposure in lupus patients.
Oct 6, 2026
0
9
More than a decade of work by two University of Wisconsin-Stout Polytechnic faculty members and their student researchers has led to a newly patented process that allows for the easy detection of an amino acid linked to multiple ...
Oct 1, 2026
0
8
An international research team has discovered a previously unknown mechanism that plays a key role in the signaling pathways involved in programmed cell death. The team identified the protein HERC4 as an essential component ...
Sep 28, 2026
0
26
Interleukin-6 (IL-6) is a contradictory molecule in immunology. It helps the liver regenerate after injury and protects against infections, yet it also drives chronic inflammation in rheumatic diseases, inflammatory bowel ...
Sep 25, 2026
0
16
People with early inflammatory arthritis could benefit from faster and more accurate diagnosis following a major international study that has established, for the first time, age-specific ultrasound standards to distinguish ...
Sep 23, 2026
0
5
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according to ...
Sep 22, 2026
0
4
